These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3944767)

  • 1. Impact of platelet activating factor on vascular responsiveness in isolated rat lungs.
    Gillespie MN; Bowdy BD
    J Pharmacol Exp Ther; 1986 Feb; 236(2):396-402. PubMed ID: 3944767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
    Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor causes pulmonary vasodilation in the rat.
    McMurtry IF; Morris KG
    Am Rev Respir Dis; 1986 Oct; 134(4):757-62. PubMed ID: 3094417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vascular response to platelet-activating factor in the perfused rat heart.
    Man RY; Hu W; Kinnaird AA
    J Lipid Mediat; 1990; 2(2):75-83. PubMed ID: 2135670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs.
    Ohar JA; Waller KS; Dahms TE
    Am Rev Respir Dis; 1993 Jul; 148(1):158-63. PubMed ID: 8317792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor augments reactivity to angiotensin II in the rat pulmonary circulation.
    Rippetoe PE; Olson JW; Altiere RJ; Pauly TH; Gillespie MN
    Am Rev Respir Dis; 1989 Sep; 140(3):821-4. PubMed ID: 2789491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet-activating factor in pneumolysin-induced acute lung injury.
    Witzenrath M; Gutbier B; Owen JS; Schmeck B; Mitchell TJ; Mayer K; Thomas MJ; Ishii S; Rosseau S; Suttorp N; Schütte H
    Crit Care Med; 2007 Jul; 35(7):1756-62. PubMed ID: 17522574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions.
    Sauvageau S; Thorin E; Caron A; Dupuis J
    J Vasc Res; 2007; 44(5):375-81. PubMed ID: 17495482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    Imai T; Vercellotti GM; Moldow CF; Jacob HS; Weir EK
    J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine treatment increases the hypoxic pulmonary vasoconstriction in isolated lungs from thyroidectomized rats.
    Herget J; Frydrychova M; Kawikova I; McMurtry IF
    Bull Eur Physiopathol Respir; 1987; 23(3):217-21. PubMed ID: 3664012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor.
    McCormack DG; Crawley DE; Barnes PJ; Evans TW
    Clin Sci (Lond); 1992 Mar; 82(3):259-64. PubMed ID: 1372199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
    Haynes J; Chang SW; Morris KG; Voelkel NF
    J Appl Physiol (1985); 1988 Nov; 65(5):1921-8. PubMed ID: 3209541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists.
    Brizzolara-Gourdie A; Webb JG
    J Pharmacol Exp Ther; 1997 Apr; 281(1):354-9. PubMed ID: 9103517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet activating factor (PAF) on pulmonary circulation in isolated rabbit lung.
    Comellas A; Tristano S; Pesce L; Friedman E; Marcano H; Sánchez de León R
    J Physiol Biochem; 1999 Mar; 55(1):1-6. PubMed ID: 10494654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
    Kempfert C; Brandt R; Siewert B; Kanowski U; Oddoy A
    Pneumologie; 1991 Oct; 45(10):799-803. PubMed ID: 1758848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.